Personalized peptide vaccination as second‐line treatment for metastatic upper tract urothelial carcinoma-Reference-Cited by-同舟云学术

Personalized peptide vaccination as second‐line treatment for metastatic upper tract urothelial carcinoma

Published:2017-10-12 Issue:12 Volume:108 Page:2430-2437
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Suekane Shigetaka¹²^ORCID,Ueda Kousuke¹,Nishihara Kiyoaki¹,Sasada Tetsuro³^ORCID,Yamashita Takuto⁴,Koga Noriko⁵,Yutani Shigeru²^ORCID,Shichijo Shigeki²,Itoh Kyogo²,Igawa Tsukasa¹,Noguchi Masanori¹²⁵^ORCID

Affiliation:

1. Department of Urology Kurume University School of Medicine KurumeJapan

2. Kurume University Cancer Vaccine Center KurumeJapan

3. Kanagawa Cancer Center YokohamaJapan

4. Biostatics Center Kurume University School of Medicine Kurume Japan

5. Division of Clinical Research Research Center for Innovative Cancer Therapy Kurume University School of Medicine Kurume Japan

Funder

Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13404

Reference26 articles.

1. Prognostic Factors in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract Experiencing Treatment Failure With Platinum-Containing Regimens

2. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma

4. Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

5. A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine approaches to treat urothelial cancer;Human Vaccines & Immunotherapeutics;2024-07-23

2. A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines;Cancers;2024-01-12

3. Nanomedicine for Combination Urologic Cancer Immunotherapy;Pharmaceutics;2023-02-06

4. Elucidation of Novel Molecular Targets for Therapeutic Strategies in Urothelial Carcinoma: A Literature Review;Frontiers in Oncology;2021-08-05

5. Evaluation of the Immunological Response of Childhood Cancer Patients Treated with a Personalized Peptide Vaccine for Refractory Soft Tissue Tumor: A Four-Case Series;The Kurume Medical Journal;2021-06-30